Financial statements Biosagitta Research

Balance sheet of Biosagitta Research

Company age:
Age:
7 y. 4 m. 17 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of BIOSAGITTA RESEARCH

Year
2018
2019
2021
2022
2023
Total assets 45 686,19 47 775,20 47 687,01 84 730,85 69 391,45
A. Fixed assets 0,00 0,00 0,00 35 312,50 30 062,50
B. Current assets 45 686,19 47 775,20 47 687,01 49 418,35 39 328,95
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 45 686,19 47 775,20 47 687,01 84 730,85 69 391,45
A. Equity 37 114,19 10 495,83 -67 078,51 -155 384,44 -147 702,51
B. Liabilities and provisions for liabilities 8 572,00 37 279,37 114 765,52 240 115,29 217 093,96
I. Long-term liabilities 0,00 0,00 0,00 119 134,50 127 324,95
II. Short-term liabilities 8 572,00 37 279,37 114 765,52 27 484,84 64 033,06
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.